Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations

Journal of Cystic Fibrosis

Volumn 14, Issue 4, 2015, Pages 482-489

  Chin, Melanie ^a   De Zoysa, Maya ^a   Slinger, Robert ^b   Gaudet, Ena ^c   Vandemheen, Katherine L ^c   Chan, Francis ^b   Hyde, Lucie ^b   Mah, Thien Fah ^a   Ferris, Wendy ^b   Mallick, Ranjeeta ^c   Aaron, Shawn D ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

CF exacerbation; Cystic fibrosis; Pseudomonas aeruginosa; Viral infection

Indexed keywords

VIRUS DNA; VIRUS RNA;

ACUTE DISEASE; ADULT; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CYSTIC FIBROSIS; DISEASE EXACERBATION; FEMALE; HUMAN; LUNG DISEASE; MALE; NONHUMAN; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT PARAMETERS; RESPIRATORY VIRUS; SPUTUM; SPUTUM ANALYSIS; SPUTUM BACTERIAL DENSITY; SPUTUM CULTURE; VIRAL RESPIRATORY TRACT INFECTION; ADOLESCENT; BACTERIAL LOAD; COMPLICATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFECTION; VIRUS INFECTION; YOUNG ADULT;

ADOLESCENT; ADULT; BACTERIAL LOAD; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS; SPUTUM; VIRUS DISEASES; YOUNG ADULT;

EID: 84937628840     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2014.11.009     Document Type: Article

References (29)

1. Goss C.H., Burns J.L. Exacerbations in cystic fibrosis 1: epidemiology and pathogenesis. Thorax 2007, 62(4):360-367.
2. Britto M.T., Kotagal U.R., Hornung R.W., Atherton H.D., Tsevat J., Wilmott R.W. Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis. Chest 2002, 121(1):64-72.
3. De Boer K., Vandemheen K.L., Tullis E., Doucette S., Fergusson D., Freitag A., et al. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. Thorax 2011, 66(8):680-685. 10.1136/thx.2011.161117.
4. Robson M., Abbott J., Webb K., Dodd M., Walsworth-Bell J. A cost description of an adult cystic fibrosis unit and cost analyses of different categories of patients. Thorax 1992, 47(9):684-689.
5. Aaron S.D., Ramotar K., Ferris W., Vandemheen K., Saginur R., Tullis E., et al. Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa. Am J Respir Crit Care Med 2004, 169(7):811-815.
6. VanDevanter D.R., Van Dalfsen J.M. How much do Pseudomonas biofilms contribute to symptoms of pulmonary exacerbation in cystic fibrosis?. Pediatr Pulm 2005, 39(6):504-506.
7. Ordoñez C.L., Henig N.R., Mayer-Hamblett N., Accurso F.J., Burns J.L., Chmiel J.F., et al. Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis. Am J Respir Crit Care Med 2003, 168(12):1471-1475.
8. Tunney M.M., Klem E.R., Fodor A.A., Gilpin D.F., Moriarty T.F., McGrath S.J., et al. Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis. Thorax 2011, 66(7):579-584. 10.1136/thx.2010.137281.
9. Regelmann W.E., Elliott G.R., Warwick W.J., Clawson C.C. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone. Am Rev Respir Dis 1990, 141(4 Pt1):914-921.
10. Smith A.L., Redding G., Doershuk C., Goldmann D., Gore E., Hilman B., et al. Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis. J Pediatr 1988, 112(4):547-554.
11. Aaron S.D., Vandemheen K., Ferris W., Fergusson D., Tullis E., Haase D., et al. Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomized, double-blind controlled clinical trial. Lancet 2005, 366(9484):463-471.
12. Reid D.W., Latham R., Lamont I.L., Camara M., Roddam L.F. Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis. J Cyst Fibros 2013 Dec, 12(6):688-699. 10.1016/j.jcf.2013.03.008.
13. Wark P.A., Tooze M., Cheese L., Whitehead B., Gibson P.G., Wark K.F., et al. Viral infections trigger exacerbations of cystic fibrosis in adults and children. Eur Respir J 2012, 40(2):510-512. 10.1183/09031936.00202311.
14. Wat D., Gelder C., Hibbitts S., Cafferty F., Bowler I., Pierrepoint M., et al. The role of respiratory viruses in cystic fibrosis. J Cyst Fibros 2008, 7(4):320-328. 10.1016/j.jcf.2007.12.002.
15. Etherington C., Naseer R., Conway S.P., Whitaker P., Denton M., Peckham D.G. The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation. J Cyst Fibros 2014, 13(1):49-55. 10.1016/j.jcf.2013.06.004.
16. Flight W.G., Bright-Thomas R.J., Tilston P., Mutton K.J., Guiver M., Morris J., et al. Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis. Thorax 2014, 69(3):247-253. 10.1136/thoraxjnl-2013-204000.
17. Smyth A.R., Smyth R.L., Tong C.Y., Hart C.A., Heaf D.P. Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch Dis Child 1995, 73(2):117-120.
18. Mallia P., Footitt J., Sotero R., Jepson A., Contoli M., Trujillo-Torralbo M.B., et al. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in COPD. Am J Respir Crit Care Med 2012, 186(11):1117-1124. 10.1164/rccm.201205-0806OC.
19. Molyneaux P.L., Mallia P., Cox M.J., Footitt J., Willis-Owen S.A., Homola D., et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013, 188(10):1224-1231. 10.1164/rccm.201302-0341OC.
20. Cystic Fibrosis Foundation Microbiology and infectious disease in cystic fibrosis. V (section 1) 1994, 1-26. Cystic Fibrosis Foundation, Bethesda.
21. Burns J.L., Emerson J., Stapp J.R., Yim D.L., Krzewinski J., Louden L., et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 1998 Jul, 27(1):158-163.
22. Anuj S.N., Whiley D.M., Kidd T.J., Bell S.C., Wainwright C.E., Nissen M.D., et al. Identification of Pseudomonas aeruginosa by a duplex real-time polymerase chain reaction assay targeting the ecfX and the gyrB genes. Diagn Microbiol Infect Dis 2009 Feb, 63(2):127-131. 10.1016/j.diagmicrobio.2008.09.018.
23. Stressmann F.A., Rogers G.B., Marsh P., Lilley A.K., Daniels T.W., Carroll M.P., et al. Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?. J Cyst Fibros 2011, 10(5):357-365. 10.1016/j.jcf.2011.05.002.
24. Carmody L.A., Zhao J., Schloss P.D., Petrosino J.F., Murray S., Young V.B., et al. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. Annu Am Thorac Soc 2013, 10(3):179-187. 10.1513/AnnalsATS.201211-107OC.
25. Fothergill J.L., Ledson M.J., Walshaw M.J., McNamara P.S., Southern K.W., Winstanley C. Comparison of real time diagnostic chemistries to detect Pseudomonas aeruginosa in respiratory samples from cystic fibrosis patients. J Cyst Fibros 2013 Dec, 12(6):675-681. 10.1016/j.jcf.2013.04.007.
26. Yamaya M. Virus infection-induced bronchial asthma exacerbation. Pulm Med 2012, 2012:834826. 10.1155/2012/834826.
27. Singanayagam A., Joshi P.V., Mallia P., Johnston S.L. Viruses exacerbating chronic pulmonary disease: the role of immune modulation. BMC Med 2012, 10:27. 10.1186/1741-7015-10-27.
28. Van Ewijk B.E., Wolfs T.F., Aerts P.C., Van Kessel K.P., Fleer A., Kimpen J.L., et al. RSV mediates Pseudomonas aeruginosa binding to cystic fibrosis and normal epithelial cells. Pediatr Res 2007 Apr, 61(4):398-403.
29. Ramirez I.A., Caverly L.L., Kalikin L.M., Goldsmith A.M., Lewis T.C., Burke D.T., et al. Differential responses to rhinovirus- and influenza-associated pulmonary exacerbations in patients with cystic fibrosis. Annu Am Thorac Soc 2014 May, 11(4):554-561. 10.1513/AnnalsATS.201310-346OC.